Tag: SAVR

Two-year Evolut Low Risk trial data shows “very favourable outcomes” for TAVI compared with SAVR

 John Forrest (New Haven, USA) sits down with Cardiovascular News to talk about the full two-yea...

STS 2020: Young patients with aortic valve disease do better with SAVR than TAVI

Open heart surgery remains the best option for young and middle-aged adults with aortic valve di...

SAVR has lower mortality and MACCE than TAVI using first-generation devices in low- and intermediate-risk patients after five years

Five-year results suggest that surgical aortic valve replacement (SAVR) is associated with lower...

PCR statement on TAVI signals “paradigm shift” in treatment of severe symptomatic AS

Evolving indications for the use of transcatheter aortic valve implantation (TAVI) have led to a...

EuroPCR 2019: PARTNER 3 results “disruptive to our practice”

Thomas Modine (Lille, France) talks to Cardiovascular News about the PARTNER 3 trial comparing l...